Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-14 Sale |
2025-03-18 5:30 pm |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
46,668 | $1.96 | $91,469 | 8,189,765 (Indirect Direct) |
View |
| 2025-02-03 Sale |
2025-02-05 4:13 pm |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
46,003 | $1.68 | $77,285 | 8,230,433 (Indirect Direct) |
View |
| 2022-03-15 Sale |
2022-03-17 5:59 pm |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
23,648 | $7.6488 | $180,879 | 5,202,848 (Indirect Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 5:00 pm |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
20,513 | $38.57 | $791,271 | 4,706,057 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-24 Option Award |
2025-01-28 8:10 pm |
N/A 2035-01-24 |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
2,504,304 | $0 | 10,228,566 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 6:01 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
344,828 | $2.9 | 7,723,302 (Direct) |
View |
| 2024-03-14 Tax Withholding |
2024-03-18 8:10 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
53,393 | $4.33 | 7,378,474 (Direct) |
View |
| 2024-01-25 Option Award |
2024-01-31 5:42 pm |
N/A 2034-01-25 |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
1,441,335 | $0 | 8,549,934 (Direct) |
View |
| 2023-03-22 Option Award |
2023-03-24 8:13 pm |
N/A 2033-03-22 |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
3,416,664 | $0 | 8,599,307 (Direct) |
View |
| 2023-03-14 Tax Withholding |
2023-03-16 5:32 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
22,340 | $5.56 | 5,182,643 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 5:51 pm |
N/A 2032-03-23 |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
2,195,512 | $0 | 2,195,512 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 08:00 am |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
27,410 | $18.22 | 5,766,665 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 08:00 am |
N/A 2030-03-18 |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
27,410 | $0 | 5,766,665 (Direct) |
View |
| 2020-08-31 Gift(A) |
2021-04-02 4:11 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
205,778 | $0 | 4,342,021 (Indirect) |
View |
| 2021-03-26 Option Award |
2021-03-30 4:57 pm |
N/A 2031-03-26 |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
379,288 | $0 | 5,085,345 (Direct) |
View |
| 2020-04-24 Other |
2020-04-28 4:32 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
18,385 | $0 | 2,892,752 (Indirect) |
View |
| 2020-03-18 Gift |
2020-04-28 4:32 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO |
428,022 | $0 | 2,892,752 (Indirect) |
View |